US Biotech Firm Moderna Says Vaccine 94.5% Effective for COVID-19
By Kyodo News 17 November 2020
WASHINGTON—Biotechnology company Moderna Inc. said Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19, making it the second US firm to show promising results in developing a vaccine against the coronavirus pandemic.
The Massachusetts-based company said it plans to apply for emergency use authorization in the United States in the coming weeks and also submit authorization applications to global regulatory agencies.
You may also like these stories: